Electronically measured peak expiratory flow and FEV1 during respiratory symptoms in asthmatic children

Electronically measured peak expiratory flow and FEV1 during respiratory symptoms in asthmatic children - Electronical Peak flow and Lung function Monitoring 5 (EPLM 5)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON30426

Enrollment

Registered

2007-02-01

Start date

2007-02-26

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

asthma

Interventions

None listed

Eligibility

Age

2 Years to 17 Years

Inclusion criteria

Inclusion criteria: - schoolchildren with dokters' diagnosed asthma, monitored by a pediatrician. - age 6-16 year - familiar with the outpatient asthma clinic in Zwolle - capable of performing reproducible lung function measurements at home - proper understanding of the dutch language - informed consent

Exclusion criteria

Exclusion criteria: - other chronic or acute disease capable of influencing the study results - airway tract infection or use of systemic corticosteroïds 4 weeks prior to the start of the study - participation in another trial - use of systemic corticosteroids and long-acting β2 sympathicomimetics.

Design outcomes

Primary

Measure	Time frame
FEV1 and PEF when children have respiratory symptoms and take bronchodilators.	—

Countries

Netherlands

Outcome results